US equities |
MU $1,086.81 ▲+3.95% SNDK $1,727.31 ▲+4.03% NVDA $237.09 ▼-0.90% AMD $645.09 ▼-0.67% SPCX $167.24 ▼-2.72% INTC $112.93 ▲+0.38% TSLA $376.42 ▼-1.12% AAPL $336.11 ▲+0.74%
FinancialContent

Medicenna Thera Corp (TSX:MDNA)

0.4450 +0.0100 (+2.30%)
Delayed Quote Updated: 12:33 PM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medicenna Thera Corp

< Previous 1 2 Next >
News headline image
Medicenna Presents Promising Preclinical Data from its First-in-Class Tumor Targeted and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the Annual 2025 AACR Meeting
From Medicenna Therapeutics Corp.
Via GlobeNewswire
News headline image
Medicenna Presents Compelling Results from the ABILITY-1 Clinical Trial at the 2025 AACR Annual Meeting
From Medicenna Therapeutics Corp.
Via GlobeNewswire
News headline image
1 High-Yield Dividend ETF to Buy to Generate Passive Income ↗
This ETF provides its investors with a premium passive-income stream. 
Via The Motley Fool
Topics ETFs
News headline image
OTC Markets Group Welcomes Medicenna Therapeutics Corp. to OTCQX
From OTC Markets
Via GlobeNewswire
< Previous 1 2 Next >